| NCT04485039 | Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate Binders | COMPLETED | PHASE4 | 2022-06-08 | 2023-04-23 | 2022-12-15 |
| NCT04957485 | Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS | ACTIVE_NOT_RECRUITING | PHASE2 | 2022-04-05 | 2026-01-01 | 2026-01-01 |
| NCT04971109 | Safety, Tolerability and Pharmacokinetics of TPOXX When Administered Orally for 28 Days | COMPLETED | PHASE3 | 2022-03-29 | 2023-05-12 | 2023-05-12 |
| NCT04392739 | Safety, Tolerability and PK of TPOXX in Adults Weighing More Than 120 KG | COMPLETED | PHASE4 | 2019-07-19 | 2019-12-05 | 2019-12-05 |
| NCT02474589 | A Trial to Assess the Safety, Tolerability, and Pharmacokinetics of the Anti-Orthopoxvirus Compound Tecovirimat | COMPLETED | PHASE3 | 2015-06-19 | 2016-08-24 | 2016-08-24 |
| NCT00907803 | Safety, Tolerability, Pharmacokinetics (PK) of the Anti-Orthopox Drug, ST-246 | COMPLETED | PHASE2 | 2009-06 | 2010-01 | 2010-01 |
| NCT00728689 | Phase I Trial of an Investigational Small Pox Medication | COMPLETED | PHASE1 | 2008-08 | 2008-10 | 2008-10 |
| NCT00431951 | Phase I, Escalating, Multiple-Dose, ST-246 Safety, Tolerability and Pharmacokinetics 21-Day Trial in Healthy Volunteers | COMPLETED | PHASE1 | 2007-02 | 2008-02 | 2008-02 |